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poorer prognosis (Peake, 2008).  Cough and 
dyspnoea are the common symptoms of lung 
cancer, which also are common complaints 
in the primary care setting (Hamilton, Peters, 
Round, & Sharp, 2005).  However, when these 
symptoms are accompanied by haemoptysis, 
alarm bells should have been sounded. 
Haemoptysis may not be present in the early 
stages, and this may cause delay in diagnosis 
of lung cancer.  Thus, this raises the concern, 
i.e. whether this could increase the risk of 
missing or delaying the diagnosis of  lung 
cancer in patients who have cough and 
dyspnoea in the primary care setting (Ellis & 
Vandermeer, 2011; Bjerager, Palshof, Dahl, 
& Olesen, 2006).
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ABSTRACT
This case report highlights delay in the diagnosis of adenoma carcinoma of the lung in a female patient 
who has never smoked.  It took three months to reach the diagnosis of stage IV lung carcinoma despite 
the presence of symptoms and an abnormal chest radiograph finding from the beginning.  The clinical 
characteristics and predictors of missed opportunities for an early diagnosis of lung cancer are discussed. 
In this case, patient and doctor factors contributed to the delay in diagnosis.  Thus, early suspicions of 
lung cancer in a woman with the presence of respiratory symptoms despite being a non-smoker are 
important in primary care setting.
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INTRODUCTION
Carcinoma of the lung is the second 
commonest cancer among men and the 
sixth most common cancer among women 
in Peninsular Malaysia (Ministry of Health, 
2008).  Lung cancer is notoriously known 
to be at an advanced stage by the time it is 
diagnosed and this unfortunately means a 
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The study by Myrdal et al. which reported that shorter delay in diagnosis might not confer 
to the better prognosis on a survival rate, which could be due to the fact that the majority of the 
patients in that study were already in the advanced stage (Myrdal G et al., 2004).  For a patient 
with a large but potentially operable tumour, however, delay may be detrimental (O’Rourke 
& Edwards, 2000).  The following case study provides an example that a greater sense of 
awareness is needed by physicians when dealing with a female patient who is a non-smoker 
but who could potentially be harbouring a lung cancer.
CASE STUDY
A 64-year-old para 4, post-menopausal housewife with underlying hypertension on diet control, 
complained  of cough, shortness of breath, haemoptysis and occasional chest pain for the past 
10 weeks.  Otherwise, she was active in terms of her activities of daily living.  She went for a 
chest radiograph (CXR) at a general practitioner’s clinic and was treated as community-acquired 
pneumonia.  She was reassured that there was no need to be worried as a course of antibiotic 
would be prescribed for her condition.  She was neither given a follow-up or a referral.  Her 
symptoms did not improve even completing the course of antibiotic.  The family members 
started to worry about her after three months of unresolved symptoms and decided to come to 
the hospital for a second opinion instead of going back to the previous doctor.
She was not a primary or secondary smoker.  She denied having any symptoms of fevers, 
night sweat and did not have any other known risk factors for developing lung cancer.  There 
was no family history of malignancy as well.
Upon examination, she appeared thin but there was no jaundice.  Dilated vein was noted 
on the anterior chest wall and finger clubbing was also present.  However, there was no cervical 
lymphadenopathy or facial swelling noted.  Her respiratory rate was 18 breaths per minute, 
blood pressure of 156/ 80 mmHg, pulse rate of 80 beats per minute with a BMI of 20.1 kg/m2.
The chest expansion and air entry were reduced together with stony dullness noted on the 
lower zone of the right lung.  There was no crepitation or rhonchi heard.  On top of that, there 
was a palpable liver, which is firm in texture and measuring about 2cm below the right costal 
margin.  Breast and spine examinations were also normal.
Investigations
The patient went for investigations which consisted of full blood count test, sputum for acid 
fast bacilli, sputum for culture and sensitivity test, chest radiograph and a Mantoux test.  The 
full blood count test showed that the patient had mild anaemia with normal white cell count and 
ESR (Table 1).  The mild anaemia could be due to the underlying chronic disease or malignancy 
in this case.  The tuberculosis workout was negative in view of the negative findings for the 
acid fast bacilli and Mantoux test (Table 2).
However, her CXR which was done in the clinic showed an ill-defined opacity and 
consolidation at the right middle lobe, with an ill-defined mass obscuring right heart border. 
There was a large right pleural effusion with an elevated right horizontal fissure seen (Figure 1). 
Subsequently Computed tomography (CT) scans (Figure 2) and bronchoscopic guided biopsy 
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of the chest were done two weeks later.  There was an irregular heterogeneously enhancing 
mass with necrotic component at the lower lobe of the right lung medial segment, measuring 
about 4.5 x 4.3x 7cm.  It showed a metastatic nodular lesion in the apical segment of the right 
lung’s lower lobe.  The left lung was clear and right hilar lymph node was enlarged by 2.1 
cm.  The right moderate pleural effusion was also present and two hypodense lesions were 
noted in the liver as well.  Histopathology examination revealed a moderately differentiated 
adenocarcinoma (stage 4 N2 M1b) of the lung.
Patient’s Progress
Despite being treated with targeted therapy (Gefitinib), the patient developed brain metastasis. 
Her condition deteriorated and she succumbed to the disease 18 months after the diagnosis.
DISCUSSION
A delay in any diagnosis of cancer is associated with substantial disability to patients (Phillips 
Jr., Bartholomew, & Dovey, 2004) and more recently, malpractice claims from physicians or 
hospitals (Singh, Sethi, & Raber, 2007).
Basically, delays could be due to three factors.  Firstly, the delay could be due to patient’s 
factors whereby the patient delays her/his decision in consulting a doctor when the symptoms 
first present.  Then, the patient may have poor adherence to the advice or appointment, or she/
he may ask for a second opinion from different health care centres, which can subsequently 
contribute to late diagnosis (Corner, Hopkinson, & Roffe, 2006).  Secondly, physician’s factors 
such as misinterpreting symptoms and treating the disease as some other diseases which 
share similar presentations cause a delay in referral.  Thirdly, “system” factors where there is 
a long waiting period for appointments, imaging or diagnostic tests (Devbhandari, Bittar, & 
Quennell, 2007) often cause further delay.  Besides all the above factors, there is more delay for 
treatment to be initiated upon diagnosis by the specialist.  In other words, it may take around 3 
to 7 months from the time of presentation before the treatment is started (Eija-Riitta, Sällinen, 
Hiekkanen, & Liippo, 2005).
The delay in the interval between the first symptom and patient’s presentation to the clinic 
is complex (Muers, Holmes, & Littlewood, 1999).  In this patient, she took 10 weeks before 
she first consulted a doctor.  This is longer compared to another study, which reported that 
the mean interval between the first symptom and patient’s visit to the family doctor was 21 
days (Koyi, Hillerdal, & Brandén, 2002).  The most common reason for the delay in the first 
consultation was the patient’s perception that the present complaint was not serious (Ellis & 
Vandermeer, 2011).
Meanwhile, the delay between the first consultation to the primary-care doctor and a 
confirmed diagnosis in the secondary care are important issue highlighted in this patient.  The 
primary-care doctor is often very busy and can easily miss the early signs and symptoms of 
lung cancer, especially if the suspicion is not kept at the back of the mind (Bjerager et al., 
2006).  This may cause the patient to go for doctor shopping, although this is not the case here. 
On top of that in the Malaysia present, neither has any established cancer control programme, 
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nor any policy for early detection of any cancer.
This may be quite challenging for the doctor who first saw her to reach the correct diagnosis. 
This is because her presenting symptoms could be due to the underlying infections like 
pneumonia or pulmonary tuberculosis, which is relatively more prevalent in Asian countries 
like Malaysia.  To further complicate matters, lung cancer also commonly presents initially 
with chest infection (Singh et al., 2010), 2010).  However, test for sputum acid-fast bacilli 
(AFB) should be performed by the doctor who initially saw her in view of the high prevalence 
of pulmonary tuberculosis in the local setting.  In a case where the sputum AFB is negative in 
the presence of an abnormal CXR finding, the patient should be referred for an early CT scan 
or seen early by the chest physician for further evaluation.  Despite haemoptysis being one 
of the cardinal and pertinent features of lung cancer (Hamilton, 2005), this symptom did not 
manage to alarm the doctor attending to this patient as she was neither given a follow-up or a 
referral following the first consultation.
The delay in diagnosis of this patient could be avoided if the initial doctor had monitored 
the patient’s progress by giving a follow-up or a safety netting where she needed to come 
back for re-evaluation if the condition did not improve.  Studies have shown that the duration 
of delay in diagnosing lung cancer could be shortened to 19 days if the predictors of missed 
opportunities for early diagnosis of lung cancer can be recognised (Singh et al., 2010).  The 
predictors identified from this study are: recurrent bronchitis (odds ratio [OR], 3.31; 95%CI, 
1.20 to 9.10), failure in following up an abnormal chest X-ray (OR, 2.07; 95% CI, 1.04 to 4.13) 
and completion of first needle biopsy (OR, 3.02; 95% CI, 1.76 to 5.18).
As for the screening of asymptomatic lung cancer, studies have shown that using a low 
dose-computered tomography demonstrated 20% reduction of lung cancer compared with 
screening with a chest radiograph (Jett, 2012).  However, with limited resources and possibility 
of high false positive (24.2%), the authors are still uncertain of its role as a tool for screening 
for lung cancer in an asymptomatic patient.
CONCLUSION
In conclusion, a higher index of suspicion of lung cancer is needed in a symptomatic non 
smoker, female patients.  The clinical features may mimic other lung conditions.  Thus, close 
follow-up for the response of a patient to treatment is of utmost importance, and if there is no 
response then referral is warranted.
TABLE 1
Full blood count of the patient
Full blood count Result Reference Range
Haemoglobin 11.8 (12.0-15.0 )g/L
White blood count 4.1 (4-10) × 109/L
Platelet 336 (150-400) × 109/L
ESR 34 mm/hr
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TABLE 2
Tuberculosis workout
Tuberculosis workout Result Reference Range
Sputum culture and sensitivity Normal upper respiratory tract flora
Sputum acid fast bacilli × 3 Negative
Mantoux test No induration (<10 mm)
Fig.1 and Fig.2: Chest radiography (left) and CT scan 
of the patient shows a right pleural effusion (right)
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